Norvegija -
norvegų -
Statens legemiddelverk
bosentan cipla 125 mg
cipla europe nv - bosentanmonohydrat - tablett, filmdrasjert - 125 mg
Norvegija -
norvegų -
Statens legemiddelverk
bosentan cipla 62.5 mg
cipla europe nv - bosentanmonohydrat - tablett, filmdrasjert - 62.5 mg
Norvegija -
norvegų -
Statens legemiddelverk
paroxetin aristo 20 mg
aristo pharma gmbh - paroksetinhydrokloridhemihydrat - tablett, filmdrasjert - 20 mg
Norvegija -
norvegų -
Statens legemiddelverk
almogran 12.5 mg
almirall, s.a. - almotriptanmalat - tablett, filmdrasjert - 12.5 mg
Norvegija -
norvegų -
Statens legemiddelverk
escitalopram bluefish 10 mg
bluefish pharmaceuticals ab - escitalopramoksalat - tablett, filmdrasjert - 10 mg
Norvegija -
norvegų -
Statens legemiddelverk
escitalopram bluefish 5 mg
bluefish pharmaceuticals ab - escitalopramoksalat - tablett, filmdrasjert - 5 mg
Norvegija -
norvegų -
Statens legemiddelverk
escitalopram bluefish 20 mg
bluefish pharmaceuticals ab - escitalopramoksalat - tablett, filmdrasjert - 20 mg
Norvegija -
norvegų -
Statens legemiddelverk
anastrozol medical valley 1 mg
medical valley invest ab - anastrozol - tablett, filmdrasjert - 1 mg
Norvegija -
norvegų -
Statens legemiddelverk
femostonconti 0.5 mg / 2.5 mg
viatris healthcare ltd. - Østradiolhemihydrat / dydrogesteron - tablett, filmdrasjert - 0.5 mg / 2.5 mg
Europos Sąjunga -
norvegų -
EMA (European Medicines Agency)
iasibon
pharmathen s.a. - ibandronsyre - hypercalcemia; fractures, bone; neoplasm metastasis; breast neoplasms - legemidler til behandling av bein sykdommer - concentrate for solution for infusion prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases. behandling av tumor-indusert hyperkalsemi med eller uten metastaser. film-coated tablets prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.